Health And Medicine
-
A switch for autoimmunity
Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies. Read MoreOct 12, 2017
-
Researcher targets peanut allergies with Cohen Fund support
Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment. Read MoreOct 12, 2017
-
VIGH receives federal grants to fight kidney disease
Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria. Read MoreOct 12, 2017
-
Major international study testing therapy to prevent spread of HIV
Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus). Read MoreOct 5, 2017
-
Mayor to speak at Center for Addiction Research science day
Nashville Mayor Megan Barry will speak during a “science day,” Tuesday, Oct. 17, at the Belcourt Theatre hosted by the Vanderbilt Center for Addiction Research (VCAR). Read MoreOct 5, 2017
-
Boosting sarcoma cell death
A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas. Read MoreOct 4, 2017
-
Cell signals that trigger wound healing are surprisingly complex
Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds. Read MoreOct 3, 2017
-
Delirium, benzos and the pediatric ICU
With other risk factors held equal, children who received a benzodiazepine sedative drug were nearly three times more likely to experience delirium – confused thought – the following day. Read MoreOct 2, 2017
-
Novel insights to antibiotic targets
New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines. Read MoreSep 29, 2017
-
Cellular calcium handling in diabetes
Potassium channels in a cellular organelle regulate calcium flux and appear to play a critical role in pancreatic beta cell health. Read MoreSep 28, 2017
-
VICC investigators land support from Komen Foundation
Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives. Read MoreSep 28, 2017
-
Excess dietary manganese increases risk of staph infection in heart
Too much dietary manganese — an essential trace mineral found in leafy green vegetables, fruits and nuts — promotes infection of the heart by the bacterium Staphylococcus aureus (“staph”). Read MoreSep 21, 2017
-
Pancreatic islets study may spur diabetes treatment advances
Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic islets, information that could lead to new treatments for diabetes. Read MoreSep 21, 2017
-
VUSN names Kleinpell assistant dean for Clinical Scholarship
Ruth Kleinpell, Ph.D., R.N., an internationally recognized nurse researcher, scholar and educator, has joined Vanderbilt University School of Nursing (VUSN) as assistant dean for Clinical Scholarship and professor of Nursing. Read MoreSep 21, 2017
-
Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs
An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy. Read MoreSep 20, 2017
-
Unique premed program teaches new approach to race and health
A premed program that teaches undergraduates about institutional racism is up and coming at Vanderbilt Read MoreSep 20, 2017
-
NSAIDs, genetics and miscarriage
A certain genetic variant, in combination with the use of anti-inflammatory drugs like aspirin and ibuprofen during early pregnancy, may protect women from miscarriage. Read MoreSep 20, 2017
-
Medication safety in the ICU
Facilitated reporting of medication-related events in the intensive care unit can provide opportunities for optimizing quality of care and patient safety. Read MoreSep 19, 2017
-
Inhibiting obesity
An enzyme in the gut – NAPE-PLD – is required for the action of signaling molecules that reduce food intake and weight gain. Read MoreSep 15, 2017
-
Acid reflux cancer link
Blocking acid reflux-induced production of reactive oxygen compounds may be a useful strategy for preventing DNA damage and decreasing the risk of esophageal cancer. Read MoreSep 14, 2017